factual

Argenx's competition is changing standard of care

For autoimmune diseases with high unmet need, the main competition is not other companies but changing standard of care and doctors' mindsets, though later competitors such as UCB and J&J will target the same biology.

factualpending

Speaker

Julia

Evidence Quote

“it's more competition of changing the standard of care”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...